Lin Jiang

2.6k total citations
54 papers, 1.9k citations indexed

About

Lin Jiang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Lin Jiang has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 17 papers in Cancer Research and 16 papers in Surgery. Recurrent topics in Lin Jiang's work include Cancer-related molecular mechanisms research (12 papers), Tissue Engineering and Regenerative Medicine (7 papers) and RNA modifications and cancer (7 papers). Lin Jiang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), Tissue Engineering and Regenerative Medicine (7 papers) and RNA modifications and cancer (7 papers). Lin Jiang collaborates with scholars based in China, United States and Hong Kong. Lin Jiang's co-authors include Yingbin Liu, Yunping Hu, Yuliang Feng, Xiangsong Wu, Maolan Li, Honghong Tan, Yang Cao, Jing Xiao, Juan Feng and Xiaojun Yang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Circulation.

In The Last Decade

Lin Jiang

53 papers receiving 1.9k citations

Peers

Lin Jiang

SURGE

ONCOL

PRM

Ning Shi China

Wen-Jia Chen China

Bao-Wei Wang Taiwan

Chunyan Gu China

Xuemei Tong China

Vivi Kasim China

Qishan Chen China

Anqi Li China

Hongwei Zhang China

Ning Shi China

Lin Jiang

768 ×0.5

432 ×0.5

254 ×0.8

SURGE

279 ×1.2

ONCOL

262 ×1.7

PRM

Citations per year, relative to Lin Jiang Lin Jiang (= 1×) peers Ning Shi

Countries citing papers authored by Lin Jiang

Since Specialization

Citations

This map shows the geographic impact of Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jiang more than expected).

Fields of papers citing papers by Lin Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jiang. The network helps show where Lin Jiang may publish in the future.

Co-authorship network of co-authors of Lin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Jiang. A scholar is included among the top collaborators of Lin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Jiang. Lin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Qiang, Yijian Zhang, Haibin Liang, et al.. (2023). EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression. Cancer Letters. 575. 216398–216398. 8 indexed citations

Li, Guoqiang, Peng Pu, Mengqiao Pan, et al.. (2023). Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer. Frontiers of Medicine. 18(1). 109–127. 3 indexed citations

Jiang, Lin, Hui Jiang, Sheng Dai, et al.. (2021). Deviation from baseline mutation burden provides powerful and robust rare-variants association test for complex diseases. Nucleic Acids Research. 50(6). e34–e34. 5 indexed citations

Jiang, Lin, Jialiang Liang, Wei Huang, et al.. (2021). CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy. Molecular Therapy. 30(1). 54–74. 32 indexed citations

Jiang, Lin, Jialiang Liang, Wei Huang, et al.. (2020). Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy. International Journal of Molecular Sciences. 21(20). 7662–7662. 3 indexed citations

Li, Huaifeng, Yunping Hu, Yunpeng Jin, et al.. (2020). Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N‐cadherin and IL‐1β‐dependent liver arrest and tumor extravasation. Clinical and Translational Medicine. 10(7). e201–e201. 12 indexed citations

Liu, Yin, Yi Xiao, Xin Hu, et al.. (2020). Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial. Cell Research. 31(2). 178–186. 194 indexed citations

Liang, Jialiang, Wei Huang, Lin Jiang, et al.. (2019). Concise Review: Reduction of Adverse Cardiac Scarring Facilitates Pluripotent Stem Cell-Based Therapy for Myocardial Infarction. Stem Cells. 37(7). 844–854. 19 indexed citations

Hu, Yunping, Yunpeng Jin, Xiangsong Wu, et al.. (2019). LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis. Molecular Cancer. 18(1). 167–167. 141 indexed citations

10.

Cai, Wenfeng, Lei Wang, Guan‐Sheng Liu, et al.. (2018). Identification of the Functional Autophagy-Regulatory Domain in HCLS1 -Associated Protein X-1 That Resists Against Oxidative Stress. DNA and Cell Biology. 37(5). 432–441. 5 indexed citations

11.

Huang, Wei, Yuliang Feng, Jialiang Liang, et al.. (2018). Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration. Nature Communications. 9(1). 700–700. 130 indexed citations

12.

Liu, Yongchen, Wang Zheng, Maolan Li, et al.. (2017). Chloride intracellular channel 1 regulates the antineoplastic effects of metformin in gallbladder cancer cells. Cancer Science. 108(6). 1240–1252. 22 indexed citations

13.

Zhang, Fei, Shanshan Xiang, Yang Cao, et al.. (2017). EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway. Cell Death and Disease. 8(6). e2868–e2868. 56 indexed citations

14.

Zhao, Shuai, Yang Cao, Shibo Liu, et al.. (2016). The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR. Journal of Experimental & Clinical Cancer Research. 35(1). 97–97. 28 indexed citations

15.

Zhu, Yanrong, Shouyin Di, Wei Hu, et al.. (2016). A new flavonoid glycoside (APG) isolated from Clematis tangutica attenuates myocardial ischemia/reperfusion injury via activating PKCε signaling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(3). 701–711. 29 indexed citations

16.

Shu, Yijun, Lin Jiang, Runfa Bao, et al.. (2015). Expression of miR-29c-5p in gallbladder cancer tissue and its clinical significance. Zhonghua putong waike zazhi. 30(9). 715–718. 1 indexed citations

17.

Li, Huai-Feng, Xuan Wang, Shanshan Xiang, et al.. (2015). Oleanolic acid induces mitochondrial-dependent apoptosis and G0/G1 phase arrest in gallbladder cancer cells. Drug Design Development and Therapy. 9. 3017–3017. 35 indexed citations

18.

Bao, Runfa, Yijun Shu, Xiangsong Wu, et al.. (2014). Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway. BMC Cancer. 14(1). 217–217. 77 indexed citations

19.

Tao, Lizhen, Xiaofeng Li, Lingling Zhang, et al.. (2011). Protective Effect of Tetrahydroxystilbene Glucoside on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway. PLoS ONE. 6(10). e26055–e26055. 55 indexed citations

20.

Jiang, Lin, Florent Allagnat, Adama Kamagaté, et al.. (2010). Plasma Membrane Ca2+-ATPase Overexpression Depletes Both Mitochondrial and Endoplasmic Reticulum Ca2+ Stores and Triggers Apoptosis in Insulin-secreting BRIN-BD11 Cells. Journal of Biological Chemistry. 285(40). 30634–30643. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact